Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of BRCA Mutation Test in the U.S., 2004-2014.

American journal of preventive medicine - 1 Jun 2017

Guo Fangjian, Hirth Jacqueline M, Lin Yu-Li, Richardson Gwyn, Levine Lyuba, Berenson Abbey B, Kuo Yong-Fang

Abstract excerpt

INTRODUCTION: BRCA mutation testing has been used for screening women at high risk of breast and ovarian cancer and for selecting the best treatment for those with breast cancer. To optimize the infrastructure and medical resources allocation for genetic testing, it is important to understand the use of BRCA mutation testing in the U.S. health system. METHODS: This retrospective cohort study included 53,254 adult...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Ovarian Neoplasms

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 28342662
DOI: 10.1016/j.amepre.2017.01.027
PMCID: PMC5370584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of BRCA Mutation Test in the U.S., 2004-2014.PMID 28342662Read ↗

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read ↗

Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.Semantic proximity Read ↗

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.Semantic proximity Read ↗

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019Semantic proximity Read ↗

BRCA1/2 Mutation Testing Among Adult Women With HER2-Negative Advanced Breast Cancer: Results From a Multi-Country, Real-World StudySemantic proximity Read ↗

BRCA mutation genetic testing implications in the United States.Semantic proximity Read ↗

BRCA testing and outcomes in women with breast cancer.Semantic proximity Read ↗

BRCA testing utilization among commercially insured women with breast or ovarian cancer.Semantic proximity Read ↗

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity Read ↗

The Role of Genetic Testing in Patients With Breast Cancer: A Review.Semantic proximity Read ↗

Genetic testing in privately insured women with surgically treated breast cancer.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.